Hydroxyl group of Tyr13 is essential for the activity of omega-conotoxin GVIA, a peptide toxin for N-type calcium channel. 1994

J I Kim, and M Takahashi, and A Ogura, and T Kohno, and Y Kudo, and K Sato
Mitsubishi Kasei Institute of Life Sciences, Tokyo, Japan.

A series of analogs of omega-conotoxin GVIA, a peptide neurotoxin having 27 amino acid residues with three disulfide bridges, were synthesized by replacing each amino acid residue except for Cys and Hyp with Ala. CD spectra were virtually identical between native and all of the analogs, indicating the overall conformations were not changed by the substitutions. The inhibitory effects of these analogs on 125I-omega-conotoxin GVIA binding to chick brain synaptic plasma membranes showed that replacement of Tyr13 with Ala drastically lowered the affinity of the toxin to the N-type Ca2+ channel. Substitution of Tyr13 with Phe also showed reduction of the affinity, indicating that the hydroxyl group of Tyr13 is critical for binding. Since Lys2 is also important for binding (Sato, K. Park, N.-G., Kohno, T. Maeda, T., Kim, J.-I., Kato, R., and Takahashi, M. (1993) Biochem. Biophys. Res. Commun. 194, 1292-1296), we propose a two-point binding model in which Tyr13 and Lys2 interact with specific amino acid residues of the Ca2+ channel through hydrogen bonding and ionic interaction, respectively.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D008978 Mollusk Venoms Venoms from mollusks, including CONUS and OCTOPUS species. The venoms contain proteins, enzymes, choline derivatives, slow-reacting substances, and several characterized polypeptide toxins that affect the nervous system. Mollusk venoms include cephalotoxin, venerupin, maculotoxin, surugatoxin, conotoxins, and murexine. Conus Venoms,Octopus Venoms,Snail Venoms,Conus Venom,Mollusc Venoms,Mollusk Venom,Octopus Venom,Snail Venom,Venom, Conus,Venom, Mollusk,Venom, Octopus,Venom, Snail,Venoms, Conus,Venoms, Mollusc,Venoms, Mollusk,Venoms, Octopus,Venoms, Snail
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002645 Chickens Common name for the species Gallus gallus, the domestic fowl, in the family Phasianidae, order GALLIFORMES. It is descended from the red jungle fowl of SOUTHEAST ASIA. Gallus gallus,Gallus domesticus,Gallus gallus domesticus,Chicken
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014443 Tyrosine A non-essential amino acid. In animals it is synthesized from PHENYLALANINE. It is also the precursor of EPINEPHRINE; THYROID HORMONES; and melanin. L-Tyrosine,Tyrosine, L-isomer,para-Tyrosine,L Tyrosine,Tyrosine, L isomer,para Tyrosine
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D017665 Hydroxyl Radical The univalent radical OH. Hydroxyl radical is a potent oxidizing agent.

Related Publications

J I Kim, and M Takahashi, and A Ogura, and T Kohno, and Y Kudo, and K Sato
October 1987, Naunyn-Schmiedeberg's archives of pharmacology,
J I Kim, and M Takahashi, and A Ogura, and T Kohno, and Y Kudo, and K Sato
October 1993, Protein science : a publication of the Protein Society,
J I Kim, and M Takahashi, and A Ogura, and T Kohno, and Y Kudo, and K Sato
March 1999, The journal of peptide research : official journal of the American Peptide Society,
J I Kim, and M Takahashi, and A Ogura, and T Kohno, and Y Kudo, and K Sato
January 2009, Journal of neurophysiology,
J I Kim, and M Takahashi, and A Ogura, and T Kohno, and Y Kudo, and K Sato
December 1991, Proceedings of the National Academy of Sciences of the United States of America,
J I Kim, and M Takahashi, and A Ogura, and T Kohno, and Y Kudo, and K Sato
October 1990, Journal of cardiovascular pharmacology,
J I Kim, and M Takahashi, and A Ogura, and T Kohno, and Y Kudo, and K Sato
May 2001, The Journal of biological chemistry,
J I Kim, and M Takahashi, and A Ogura, and T Kohno, and Y Kudo, and K Sato
January 1996, Clinical and experimental pharmacology & physiology,
J I Kim, and M Takahashi, and A Ogura, and T Kohno, and Y Kudo, and K Sato
November 2007, The Journal of pharmacology and experimental therapeutics,
J I Kim, and M Takahashi, and A Ogura, and T Kohno, and Y Kudo, and K Sato
November 1986, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!